RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Amyotrophic Lateral Sclerosis (ALS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Sep 2011 - 80 pages - $3,500
Amyotrophic Lateral Sclerosis Therapy Area Pipeline Report
Nov 2010 - 144 pages - $1,495
The Market Outlook for Neurodegenerative Diseases
Sep 2010 - 137 pages - $3,835
Amyotrophic Lateral Sclerosis - Pipeline Review, Q1 2011
Feb 2011 - 69 pages - $500
Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2011
Sep 2011 - 122 pages - $500
Stakeholder Opinions: Diagnostics in Neurology - Predictive biomarkers expand drug revenues
Jul 2008 - 152 pages - $3,800
Personalized Medicine Partnering Terms and Agreements
Apr 2011 - 951 pages - $4,995
Amyotrophic Lateral Sclerosis Global Clinical Trials Review, Q1, 2011
Feb 2011 - 69 pages - $1,000
Advances in Drug-Diagnostic Co-Development
May 2011 - 102 pages - $3,835
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) - Pipeline Assessment and Market Forecasts to 2017
Nov 2010 - 35 pages - $2,000
More Related Market Research Reports >>>

Your selection

Industry sector
Diagnostic del
Biomarker-based diagnostics del
Therapeutic target
Central Nervous System del
Amyotrophic lateral sclerosis del
Year
2010 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us